Menu
Close
Stories & News
Resources
Stay Informed
x
Stay Informed
November 14, 2023
Pfizer redefines the limits of scientific discovery every day, applying over 170 years of life-changing innovations to build a brighter and better future.
The company’s purpose—breakthroughs that change patients' lives—fuels everything it does. The company’s dedicated colleagues around the world continue to live this purpose every day.
As a result of our commitment to patients and innovation, in 2022 more than 1.3 billion patients around the world were treated with Pfizer’s medicines and vaccines.* The company also made significant strides in strengthening its R&D pipeline and deploying capital into growth-focused business development to access external science. Pfizer continues to take bold steps to position the company for long-term growth potential.
Take this quiz to test your knowledge about Pfizer’s purpose, values, environmental, social, and governance (ESG) priorities and efforts the company has been making to deliver meaningful value for patients, investors and all stakeholders.
Thank you for participating in our quiz.
*The patients treated metric is calculated from Pfizer and third-party datasets. Figures may be limited given the coverage provided by external sources (e.g., calendar duration, geographic and product coverage). Numbers are estimates and in some cases use global volume, daily dosage and number of treatment days to facilitate calculations. Methodologies to calculate estimates may vary by product type given the nature of the product and available data. Patients taking multiple Pfizer products may be counted as multiple patients towards total. Numbers include estimated patient counts from U.S. Patient Assistance Programs, ex-U.S. access & affordability programs, product donations and Global Commercial Access Partnerships (this does not include An Accord for a Healthier World). Historical estimates may periodically be subject to revision due to restatements in the underlying data source.
Forward-looking statements included herein are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. We encourage you to read our reports filed with the U.S. Securities and Exchange Commission (SEC), including the sections captioned “Risk Factors” and “Forward Looking Information and Factors that May Affect Future Results,” for a description of such substantial risks and uncertainties. These reports are available at pfizer.com and the SEC’s website at www.sec.gov.
Forward-looking statements included herein are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. We encourage you to read our reports filed with the U.S. Securities and Exchange Commission (SEC), including the sections captioned “Risk Factors” and “Forward Looking Information and Factors that May Affect Future Results,” for a description of such substantial risks and uncertainties. These reports are available at pfizer.com and the SEC’s website.
Copyright © 2002 – 2025 Pfizer Investor Insights All rights reserved. This information—including product information—is intended only for residents of the United States. The products discussed herein may have different labeling in different countries. This website contains certain information about Pfizer, but may not contain all information that is material to Pfizer.